XML 47 R23.htm IDEA: XBRL DOCUMENT
v3.21.2

Note 4 - Acquisitions (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2021
Notes Tables |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
|  | Preliminary Allocation at Acquisition Date |  |  | Adjustments to Fair Value |  |  | Final Allocation at June 30, 2021
Current assets, net of cash |  | $ | 3,145 |  |  | $ | - |  |  | $ | 3,145
Equipment and other long-term assets |  |  | 1,639 |  |  |  | - |  |  |  | 1,639
Intangible assets: |  |  |  |  |  |  |  |  |  |  |
Developed technology |  |  | 6,778 |  |  |  | - |  |  |  | 6,778
Customer relationships |  |  | 2,133 |  |  |  | - |  |  |  | 2,133
Goodwill |  |  | 8,811 |  |  |  | (963 | ) |  |  | 7,848
Total assets acquired |  |  | 22,506 |  |  |  | (963 | ) |  |  | 21,543
Liabilities |  |  | 1,436 |  |  |  | - |  |  |  | 1,436
Deferred income taxes, net |  |  | 2,320 |  |  |  | (963 | ) |  |  | 1,357
Net assets acquired |  | $ | 18,750 |  |  | $ | - |  |  | $ | 18,750
Cash paid, net of cash acquired |  |  | 9,765 |  |  |  | - |  |  |  | 9,765
Fair value of noncontrolling interest in Eminence |  |  | 8,985 |  |  |  | - |  |  |  | 8,985
Net assets acquired |  | $ | 18,750 |  |  | $ | - |  |  | $ | 18,750
|  |  |  | Preliminary allocation at acquisition date and at June 30, 2021
Current assets, net of cash |  |  |  | $ | 10,422
Equipment and other long-term assets |  |  |  |  | 3,762
Intangible assets: |  |  |  |  |
Developed technology |  |  |  |  | 107,000
In-process research and development |  |  |  |  | 22,700
Customer relationships |  |  |  |  | 11,700
Tradenames |  |  |  |  | 2,000
Non-competition agreement |  |  |  |  | 1,000
Goodwill |  |  |  |  | 94,970
Total assets acquired |  |  |  |  | 253,554
Liabilities |  |  |  |  | 4,003
Deferred income taxes, net |  |  |  |  | 15,664
Net assets acquired |  |  |  | $ | 233,887
Cash paid, net of cash acquired |  |  |  |  | 215,587
Contingent consideration payable |  |  |  |  | 18,300
Net assets acquired |  |  |  | $ | 233,887
|  | B-MoGen Biotechnologies |  |  | Exosome Diagnostics |  |  | Quad Technologies
Current assets, net of cash |  | $ | 504 |  |  | $ | 2,611 |  |  | $ | 36
Equipment and other long-term assets |  |  | 269 |  |  |  | 2,212 |  |  |  | 228
Intangible assets: |  |  |  |  |  |  |  |  |  |  |
Developed technology |  |  | 14,000 |  |  |  | 105,000 |  |  |  | 12,256
Trade name |  |  | - |  |  |  | 58,000 |  |  |  | -
Customer relationships |  |  | 400 |  |  |  | 2,300 |  |  |  | -
Goodwill |  |  | 16,131 |  |  |  | 105,362 |  |  |  | 14,481
Total assets acquired |  |  | 31,304 |  |  |  | 275,485 |  |  |  | 27,001
Liabilities |  |  | 211 |  |  |  | 3,716 |  |  |  | 296
Deferred income taxes, net |  |  | 3,051 |  |  |  | 16,346 |  |  |  | 943
Net assets acquired |  | $ | 28,042 |  |  | $ | 255,423 |  |  | $ | 25,762
Cash paid, net of cash acquired |  |  | 17,448 |  |  |  | 251,623 |  |  |  | 20,462
Additional consideration(1) |  |  | 10,594 |  |  |  | 3,800 |  |  |  | 5,300
Net assets acquired |  | $ | 28,042 |  |  | $ | 255,423 |  |  | $ | 25,762

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration